William Webster, MD
Otolaryngology · Coos Bay, ORNPI 1528166287
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,680 of the $1,833 with a category attached, or 91.6%. Medical Device Business Services, Inc. accounts for 93.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $1,730 and has fallen 97.7% since, to $40 in 2025.
Across 8 payments — averaging $229.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$46
- Mimedx Group, Inc.$22
- Ascendis Pharma Endocrinology Inc$22
- Intersect ENT, Inc.$19
- Stryker$14
What the payments were for
- Travel & lodging$1,68092%
- Food & beverage$1538%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $1,711 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Mimedx Group, Inc. | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Intersect ENT, Inc. | 1 | $19 |
| Stryker | 1 | $14 |
How this compares
$1,833 in reported general payments places this provider in the 75th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 70 | $1,888 |
| Azelastine Hcl | 55 | $1,615 |
| Asmanex HfaMometasone Furoate | 13 | $1,567 |
| Famotidine | 68 | $660 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $653 |
| Fluticasone Propionate | 53 | $618 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $571 |
| Mupirocin | 70 | $444 |
| Doxycycline Hyclate | 47 | $396 |
| Prednisone | 77 | $352 |
| Ofloxacin | 29 | $340 |
| Montelukast Sodium | 13 | $229 |
| Azithromycin | 36 | $213 |
| Nystatin | 17 | $200 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $149 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Coos Bay
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
- Daniel ClayburghPortland$7K
- Timothy HullarPortland$7K
- Paul FlintPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.